LEI: 213800ZHXS8G27RM1D97

22 December 2023

Titon Holdings Plc

Confirmation of Board Appointment

Titon Holdings Plc ("Titon", the "Group" or the "Company"), a leading manufacturer and supplier of ventilation systems and window and door hardware, is pleased to confirm, further to the announcement on 29 November 2023, the appointment of Jamie Brooke as Non-Executive Chair. Jamie will join the Board on 2 January 2024.  Paul Hooper, currently Interim Chair, will be appointed as Senior Independent Non-Executive Director from 2 January 2024.

Paul Hooper, Interim Chair, commented:

"We are very pleased to welcome Jamie Brooke as our new Chair commencing on 2 January 2024. Jamie brings a wealth of small cap experience both as a professional investor but also as an experienced non-executive director of AIM companies.''

Jamie Brooke, Incoming Non-Executive Chair, commented:

"I am delighted to be taking on the role of Chair at Titon as it continues to grow its share of the ventilation systems and window and door hardware markets.  I look forward to working with the wider Board and leadership team and in particular, welcoming Tom Carpenter as the new Chief Executive in April. This is an exciting time for the business to execute its strategy and growth plans and deliver value for shareholders."

Regulatory disclosures

In accordance with Schedule 2(g) of the AIM Rules, James (Jamie) Dominic Brooke, aged 52, holds or has held in the past 5 years the following directorships and partnerships:

Jamie Brooke is a director of Redhall Group Plc, which entered into administration on 10 June 2019 and compulsory liquidation on 14 July 2023. The total deficiency to creditors was approximately £12.9 million. Jamie Brooke was a director of Flowgroup Plc until 1 March 2022, which entered into administration on 8 November 2018 and voluntary creditors liquidation on 8 October 2019, the total deficiency of the Company was £94.1 million. The liquidation process is ongoing.

Jamie holds no interest in the ordinary share capital of the Company. There is no further information required to be disclosed in respect of the above appointment pursuant to Rule 17 and Schedule 2 (g) of the AIM Rules for Companies.

For further information please contact: